|
[1] SASAKI H, KOHSAKA H. Current diagnosis and treatment of polymyositis and dermatomyositis[J]. Mod Rheumatol, 2018.[Epub ahead of print]
|
|
[2] MASON A, THEAL J, BAIN V, et al. Hepatitis B virus replication in damaged endothelial tissues of patients with extrahepatic disease[J].AM J Gastroenterol, 2005, 100 (4) :972-976.
|
|
[3] SHU XM, MA L, LU X, et al. Myositis disease activity tool in Chinese patients with polymyositis/dermatomyositis[J]. Natl Med China, 2011, 91 (19) :1382-1330.
|
|
[4] WANG WY, YANG J, LU S, et al. A case of primary biliary cirrhosis complicated by dermatomyositis without dermatitis[J]. J Clin Hepatol, 2012, 31 (2) :269-272. (in Chinese) 汪维艳, 杨京, 陆爽, 等.原发性胆汁性肝硬化伴无皮炎性皮肌炎1例报告[J].临床肝胆病杂志, 2012, 31 (2) :269-272.
|
|
[5] KEE KM, WANG JH, LEE CM, et al. Chronic hepatitis C virus infection associated with dermatomyositis and hepatocellular carcinoma[J].Chang Gung Med J, 2004, 27 (11) :834-838.
|
|
[6] ANDRAS C, PONYI A, CONSTANIN T. Dermatomyositis and polymyositis associated with malignancy:A 21-year retrospective study[J]. J Rheumatol, 2008, 35 (3) :438-444.
|
|
[7] KEE SJ, KIM TJ, LEE SJ, et al. Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma[J]. Rheumatol Int, 2009, 29 (5) :959-599.
|
|
[8] YANG SY, CHA BK, KIM G, et al. Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma[J]. Korean J Intern Med, 2015, 29 (2) :231-235.
|
|
[9] European Association for the Study of the Liver. EASL clinical practice guidelines:Management of chronic hepatitis B virus infection[J]. J Hepatol, 2012, 57 (1) :167-185.
|
|
[10] FASANO M, LAMPERTICO P, MARZANO A. HBV DNA suppression and HBs Ag clearance in HBe Ag negative chronic hepatitis B patients on lamivudine therapy for over 5 years[J]. J Hepatol, 2012, 56 (6) :1254-1258.
|
|
[11] AYGEN B, DEMIR AM, KARABAY O, et al. Immunosuppressive therapy and the risk of hepatitis B reactivation:Consensus report[J]. Turk J Gastroenterol, 2018, 29 (3) :259-269.
|
DownLoad: